Showing results (51-60 of 389) with videos related to
Sort By:
Pageof 39
British Journal of Haematology|October 17, 2024
What is the best second-line treatment for immune thrombocytopenia?Matthieu Mahévas, James B BusselPresse Medicale (Paris, France : 1983)|April 1, 2014
Thrombopoietic agents: there is still much to learnJames B Bussel, Madhavi LakkarajaAmerican Journal of Hematology|November 17, 2006
Safety and tolerability of a novel chromatography-based intravenous immunoglobulin when administered at a high infusion rate in patients with immune thrombocytopenic purpuraJames B Bussel, Kim Hanna, British Journal of Haematology|August 3, 2022
Should dexamethasone alone or in combination be the initial steroid for adult ITP: Still a relevant questionBarbara Skopec, James B BusselCurrent Rheumatology Reports|April 29, 2010
The long-term impact of rituximab for childhood immune thrombocytopeniaNichola Cooper, James B BusselBlood Reviews|November 6, 2007
Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debatesJames B Bussel, Andrea PrimianiClinical Lymphoma & Myeloma|May 27, 2008
Overview of thrombopoietic agents in the treatment of thrombocytopeniaRachel Kobos, James B BusselSeminars in Hematology|April 2, 1998
Clinical experience with anti-D in the treatment of idiopathic thrombocytopenic purpuraA Scaradavou, J B BusselCurrent Opinion in Pediatrics|January 17, 2008
Diagnosis, pathophysiology and management of children with refractory immune thrombocytopenic purpuraRam Kalpatthi, James B BusselPageof 39